Report overview
The global Smart Drug Delivery Systems market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Connected Inhalers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Smart Drug Delivery Systems include Abbott Laboratories, Adherium Ltd., Amiko Digital Health Limited, Becton, Dickinson and Company, BIOCORP, CeQur Corporation, Cognita Labs, E3D Elcam Drug Delivery Devices and H&T Presspart Manufacturing Ltd., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Smart Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Smart Drug Delivery Systems. This report contains market size and forecasts of Smart Drug Delivery Systems in global, including the following market information:
Global Smart Drug Delivery Systems Market Revenue, 2020-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Smart Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Smart Drug Delivery Systems Market, by Product, 2020-2024, 2025-2030 ($ millions)
Global Smart Drug Delivery Systems Market Segment Percentages, by Product, 2023 (%)
Connected Inhalers
Connected Autoinjectors
Connected Pen Injectors
Connected Wearable Injectors
Others
Global Smart Drug Delivery Systems Market, by Application, 2020-2024, 2025-2030 ($ millions)
Global Smart Drug Delivery Systems Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics
Home Care
Ambulatory Care Settings
Others
Global Smart Drug Delivery Systems Market, By Region and Country, 2020-2024, 2025-2030 ($ Millions)
Global Smart Drug Delivery Systems Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Smart Drug Delivery Systems revenues in global market, 2020-2024 (estimated), ($ millions)
Key companies Smart Drug Delivery Systems revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Adherium Ltd.
Amiko Digital Health Limited
Becton, Dickinson and Company
BIOCORP
CeQur Corporation
Cognita Labs
E3D Elcam Drug Delivery Devices
H&T Presspart Manufacturing Ltd.
HCmed Innovations Co., Ltd.
Medtronic plc
Novo Nordisk A/S
Phillips-Medisize
Sonceboz
Outline of Major Chapters:
Chapter 1: Introduces the definition of Smart Drug Delivery Systems, market overview.
Chapter 2: Global Smart Drug Delivery Systems market size in revenue.
Chapter 3: Detailed analysis of Smart Drug Delivery Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by product, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Smart Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
